Abstract
Pharmaceutical Patent AnalystVol. 1, No. 2 Hot TopicUS patent reform 2011: a few things to rememberSmitha B Uthaman, Deborah L Lu & Thomas J KowalskiSmitha B Uthaman* Author for correspondenceVedder Price PC, 1633 Broadway, 47th Floor, New York, NY 10019, USA. Search for more papers by this authorEmail the corresponding author at suthaman@vedderprice.com, Deborah L LuVedder Price PC, 1633 Broadway, 47th Floor, New York, NY 10019, USASearch for more papers by this author & Thomas J KowalskiVedder Price PC, 1633 Broadway, 47th Floor, New York, NY 10019, USASearch for more papers by this authorPublished Online:10 May 2012https://doi.org/10.4155/ppa.12.11AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleReferences1 The US Constitution. Article 1 – Section 8 (1787).Google Scholar2 Leahy–Smith America Invents Act. H.R. 1249 (2011).Google Scholar3 Microsoft Corp. v. i4i Ltd. Partnership, 564 US _ (2011).Google Scholar101 NY Times. Senate passes bill to change patent system and pricing by Edward Wyatt. www.nytimes.com/2011/03/09/business/09patent.html (Accessed 18 January 2012)Google ScholarFiguresReferencesRelatedDetailsCited ByBiofuel Impact on Diesel Engine After-Treatment: Deactivation Mechanisms and Soot Reactivity18 December 2017 | Emission Control Science and Technology, Vol. 4, No. 1Vanadia-Based Catalysts for Mobile SCR15 March 2014 Vol. 1, No. 2 Follow us on social media for the latest updates Metrics Downloaded 260 times History Published online 10 May 2012 Published in print May 2012 Information© Future Science LtdFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
